Aster DM Healthcare Limited (ASTERDM.NS)
INR 492.7
(-0.46%)
INR 492.7
(-0.46%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 9.4 Billion INR | -54.47% |
| 2022 | 7.86 Billion INR | -6.84% |
| 2021 | 8.43 Billion INR | 88.58% |
| 2020 | 4.47 Billion INR | -33.91% |
| 2019 | 6.77 Billion INR | 16.03% |
| 2018 | 5.83 Billion INR | 48.19% |
| 2017 | 3.93 Billion INR | 1191.31% |
| 2016 | 304.96 Million INR | -86.75% |
| 2015 | 2.3 Billion INR | -38.69% |
| 2014 | 3.75 Billion INR | 8.7% |
| 2013 | 3.45 Billion INR | 79.77% |
| 2012 | 1.92 Billion INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 1.03 Billion INR | 2.13% |
| 2024 Q2 | 1.57 Billion INR | 52.69% |
| 2023 Q2 | 1.51 Billion INR | -11.07% |
| 2023 Q3 | 3.32 Billion INR | 119.35% |
| 2023 Q4 | 1 Billion INR | -69.59% |
| 2023 FY | 3.57 Billion INR | -54.47% |
| 2023 Q1 | 1.7 Billion INR | -43.58% |
| 2022 Q1 | 1.33 Billion INR | -61.64% |
| 2022 Q2 | 1.47 Billion INR | 11.09% |
| 2022 Q3 | 2.6 Billion INR | 76.31% |
| 2022 FY | 7.86 Billion INR | -6.84% |
| 2022 Q4 | 3.01 Billion INR | 15.75% |
| 2021 FY | 8.43 Billion INR | 88.58% |
| 2021 Q4 | 3.46 Billion INR | 15.58% |
| 2021 Q3 | 3 Billion INR | 20.46% |
| 2021 Q2 | 2.49 Billion INR | 24.0% |
| 2021 Q1 | 2 Billion INR | -59.89% |
| 2020 Q3 | 1.7 Billion INR | 44.4% |
| 2020 Q2 | 1.18 Billion INR | 1086.23% |
| 2020 Q1 | -119.8 Million INR | -104.53% |
| 2020 FY | 4.47 Billion INR | -33.91% |
| 2020 Q4 | 5.01 Billion INR | 193.72% |
| 2019 Q3 | 2.45 Billion INR | 155.99% |
| 2019 Q2 | 958.3 Million INR | -1.88% |
| 2019 FY | 6.77 Billion INR | 16.03% |
| 2019 Q1 | 976.7 Million INR | -67.38% |
| 2019 Q4 | 2.64 Billion INR | 7.83% |
| 2018 Q1 | 501.6 Million INR | -75.81% |
| 2018 FY | 5.83 Billion INR | 48.19% |
| 2018 Q4 | 2.99 Billion INR | 62.47% |
| 2018 Q3 | 1.84 Billion INR | 271.29% |
| 2018 Q2 | 496.4 Million INR | -1.04% |
| 2017 Q3 | 1.03 Billion INR | 138.36% |
| 2017 Q1 | -386.9 Million INR | 0.0% |
| 2017 FY | 3.93 Billion INR | 1191.31% |
| 2017 Q4 | 2.07 Billion INR | 101.17% |
| 2017 Q2 | 432.5 Million INR | 211.79% |
| 2016 FY | 304.96 Million INR | -86.75% |
| 2015 FY | 2.3 Billion INR | -38.69% |
| 2014 FY | 3.75 Billion INR | 8.7% |
| 2013 FY | 3.45 Billion INR | 79.77% |
| 2012 FY | 1.92 Billion INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Apollo Hospitals Enterprise Limited | 57.35 Billion INR | 83.603% |
| Artemis Medicare Services Limited | 1.6 Billion INR | -486.041% |
| Fortis Healthcare Limited | 9.25 Billion INR | -1.566% |
| HealthCare Global Enterprises Limited | 92.8 Million INR | -10034.052% |
| Indraprastha Medical Corporation Limited | 1.55 Billion INR | -504.047% |
| Krishna Institute of Medical Sciences Limited | 14.32 Billion INR | 34.366% |
| Lotus Eye Hospital and Institute Limited | 100.54 Million INR | -9253.052% |
| Max Healthcare Institute Limited | 22.35 Billion INR | 57.935% |
| Max India Limited | -641.96 Million INR | 1564.947% |
| Global Health Limited | 11.71 Billion INR | 19.69% |
| Narayana Hrudayalaya Limited | 16.49 Billion INR | 42.983% |
| Rainbow Children's Medicare Limited | 5.94 Billion INR | -58.155% |
| Shalby Limited | 2.23 Billion INR | -319.961% |